Halberd

Home>Halberd

About Halberd

This author has not yet filled in any details.
So far Halberd has created 5 blog entries.
Jul 27 2020

Retired NFL Great Carl Eller Joins Halberd Corporation

By |2020-07-30T17:30:57-04:00July 27th, 2020|Featured, Investor News, News|0 Comments

Will Assist with Covid-19 Efforts and the Brain Jackson Center, PA, July 27, 2020 – Halberd Corp. (OTC PINK: "HALB") announced the appointment of Carl Eller, retired NFL Pro Football Hall of Famer, and President of the NFL Retired Players Association as a consultant.  Mr. Eller’s expertise and contacts will be leveraged as part of ...

Jul 22 2020

Halberd Corporation CTO, Dr. Patricio Reyes, Presents Information at Virtual Event on Covid-19’s Effects on Neurological Functions

By |2020-07-30T12:19:33-04:00July 22nd, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, July 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced their Chief Technical Officer and Head of Scientific Advisory Board, Dr. Patricio Reyes, presented A Community Information Session virtual event hosted yesterday by the Brain Injury Alliance of Arizona, on “Covid-19 & the Nervous System; Neurological Complications That Can Result”.  Dr. Reyes ...

Apr 8 2020

Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier’s Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction PatchTM

By |2020-04-08T21:24:15-04:00April 8th, 2020|News|Comments Off on Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier’s Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction PatchTM

Jackson Center, PA, April 8, 2020 – Premier Biomedical, Inc. (OTC-PINK: “BIEI“), Halberd Corporation (OTC-PINK: HALB) and Gold River Productions Inc. (OTC-PINK: GRPS) announce the signing of a multi-faceted agreement for ongoing R&D into a potential treatment and cure for Covid-19 as well as development of Premier’s Anti-Addiction PatchTM. The Joint Venture on Covid-19 treatment starts with Dr. Mitchell ...

Apr 6 2020

Halberd Announces Agreement To Retire 192,000,000 Outstanding Common Shares

By |2020-04-06T18:24:14-04:00April 6th, 2020|News|Comments Off on Halberd Announces Agreement To Retire 192,000,000 Outstanding Common Shares

Halberd announces agreement to retire 192,000,000 outstanding common shares and acquisition/joint venture to be announced, in detail, this week. Lake Charles, Louisiana -- April 3, 2020 - Halberd Corporation (PINKSHEETS: HALB) announces that it has reached an agreement with shareholders holding 192,000,000 shares of the 482,838,125 reported as currently outstanding. Those shares will be returned to ...

Apr 1 2020

Halberd Moves Forward

By |2020-07-17T12:20:34-04:00April 1st, 2020|News|Comments Off on Halberd Moves Forward

Halberd moves forward – announces new CEO, commences process to become current, holding company reorganization. SOUTHFIELD, MI-- April 1, 2020 - Halberd Corporation (PINKSHEETS: HALB) announces that James Christopher LeDoux is the new CEO. Mr. LeDoux explains that “Halberd is now current in its filings with the Colorado Secretary of State. The Colorado state filings ...

Go to Top